Information from around the world taken from Clinical Trials, Research literature and News feeds relevant to the Alkaptonuria (AKU) community, sorted for you by the following categories: Alkaptonuria Research, General Information on Alkaptonuria, Alkaptonuria Research 2, AKU Clinical Trials, AKU Research 3, AKU Research 4, AKU Research 5, AKU Research 6, AKU Research 7, AKU in the News.

  • AKU in the News

    • -
      Tony goes to the NIH for Exams Related to AKU
      Google BlogSearch, 2012-04-28 00:00:00


      Follow Tony's blog: I’m at the National Institutes of Health this week to have a barrage of tests, the results of which will be added to the AKU knowledge base.

    • -
      Article in Express UK on Simon Laxon and AKU
      Google BlogSearch, 2012-03-13 00:00:00


      Eventually tests revealed Simon was suffering from a rare genetic condition called alkaptonuria (AKU) which causes homogentisic acid to build up in the body. The acid is expelled in the urine and changes to a dark colour a few hours after exposure to air. The condition is known as black bone disease.

    • -
      New Cases of Rare Genetic Disorder Identified
      Google BlogSearch, 2012-02-05 00:00:00


      Researchers have identified more than 100 new cases of the disease, called alkaptonuria (AKU) in a small community in Vellore, India, bringing the total number of patients there to 130.

  • AKU Research 3

    • -
      Ochronosis: report of two familial cases.
      Alkaptonuria (AKU) PubMed, 2011-02-01 00:00:00



      Background : Ochronosis of alkaptonuria is a rare hereditary autosomal recessive disease in wich there is an absence of homogentisic acid oxidase resulting in accumulation of homogentisic acid in tissues. Aim: To report a new case of

    • -
      Nine cases of Alkaptonuria in one family in southern Jordan
      Alkaptonuria (AKU) PubMed, 2010-12-03 00:00:00



      Alkaptonuria is a rare autosomal recessive metabolic disorder characterized by a deficiency of homogentisate 1,2-dioxygenase (HGO) in the liver. This results in excretion of large quantities of homogentisic acid (HGA) (also called...

    • -
      Dermatology Online Journal: Alkaptonuria (2010)
      Google BlogSearch, 2010-11-01 00:00:00


      A 69-year-old woman presented with a 30-year history of lower back and large joint pain of the hips and shoulders. On examination blue-grey, pigmented macules were present over the cartilaginous portions of the ears and on the sclera....

  • AKU Research 6

    • -
      A Patient’s Journey- Living with alkaptonuria
      Google BlogSearch, 2011-10-26 00:00:00


      Simon Laxon, who was diagnosed with a rare genetic disorder, alkaptonuria, soon after birth, describes his journey in understanding the condition and finding hope for a cure. 

    • -
      Alkaptonuria: Treasure your exceptions
      Recent scientific publications, 2011-09-27 00:00:00


      Full text article via Springer publishers: This editorial is part of a review about the scientific heritage of rare human disorders and the genetic dissection of biochemical pathways.Alkaptonuria and other disorders of aromatic amino acid metabolism have a special place in this legacy. 

    • -
      Nuclear medicine techniques in the assessment of alkaptonuria.
      Google BlogSearch, 2011-08-30 00:00:00


      We believe that, currently, nuclear medicine techniques can provide useful information, which can be incorporated into disease severity scores for alkaptonuria. Once the biological basis for alkaptonuria is better understood, it is feasible that..

  • Alkaptonuria Research

    • -
      Cardiovascular manifestations of Alkaptonuria
      Alkaptonuria (AKU) PubMed, 2011-04-20 00:00:00


      Abstract
      The cardiovascular manifestations of alkaptonuria relate to deposition of ochronotic pigment within heart valves, endocardium, aortic intima and coronary arteries. We assessed 16 individuals with alkaptonuria for cardiovascular disease, including full electrocardiographic and echocardiographic assessment....

    • -
      “Clinical, Biochemical, and Molecular Investigations Into Alkaptonuria”
      AKU Clinical Trials, 2011-04-15 06:00:00


      Status: Recruiting, Condition Summary: Alkaptonuria

    • -
      Novel mutations in the homogentisate 1,2 dioxygenase gene identified in Jordanian patients with alkaptonuria.
      Alkaptonuria (AKU) PubMed, 2011-03-25 00:00:00


      Abstract

      This study was conducted to identify mutations in the homogentisate 1,2 dioxygenase gene (HGD) in alkaptonuria patients among Jordanian population. Blood samples were collected from four alkaptonuria patients, four carriers, and two healthy volunteers. DNA was isolated from peripheral blood. All 14 exons of the HGD gene were amplified using the polymerase chain reaction (PCR) technique. The PCR products were then purified and analyzed by sequencing. Five mutations were identified in our samples. Four of them were novel C1273A, T1046G, 551-552insG, T533G and had not been previously reported, and one mutation T847C has been described before. The types of mutations identified were two missense mutations, one splice site mutation, one frameshift mutation, and one polymorphism. We present the first molecular study of the HGD gene in Jordanian alkaptonuria patients. This study provides valuable information about the molecular basis of alkaptonuria in Jordanian population.

  • Alkaptonuria Research 2

    • -
      Collagen atomic scale molecular disorder in ochronotic cartilage from an alkaptonuria patient, observed by solid state NMR
      Recent scientific publications, 2011-07-09 00:00:00


      In pilot studies of the usefulness of solid state nuclear magnetic resonance spectroscopy in characterizing chemical and molecular structural effects of alkaptonuria on connective tissue, we have obtained (13) C spectra from articular cartilage...

    • -
      An update on molecular genetics of Alkaptonuria (AKU)
      Recent scientific publications, 2011-07-01 00:00:00


      Alkaptonuria (AKU) is an autosomal recessive disorder caused by a deficiency of homogentisate 1,2 dioxygenase (HGD) and characterized by homogentisic aciduria, ochronosis, and ochronotic arthritis. The defect is caused by mutations in...

    • -
      A 3-year randomized therapeutic trial of nitisinone in alkaptonuria.
      Recent scientific publications, 2011-06-01 00:00:00


      Alkaptonuria is a rare, autosomal recessive disorder of tyrosine degradation due to deficiency of the third enzyme in the catabolic pathway. As a result, homogentisic acid (HGA) accumulates and is excreted in gram quantities in the urine, which turns dark upon alkalization. The first symptoms, occurring in early adulthood, involve a painful, progressively debilitating arthritis of the spine and large joints....

  • General Information on Alkaptonuria

    • -
      The AKU Guide for Rare Disease Patient Groups
      Google BlogSearch, 2011-01-01 00:00:00


      There are 7,000 rare diseases. AKU is just one of them, although it has a place in the history books for being the first metabolic disease ever identified, in 1901. This blog provides advice, tips and suggestions for the wider rare disease movement based on our experience on AKU. Please read on and don't hesitate to comment.

    • -
      Article on Alkaptonuria from GeneReviews
      Google BlogSearch, 2009-07-09 00:00:00


      Summary

      Disease characteristics. Alkaptonuria is caused by deficiency of homogentisate 1,2-dioxygenase, an enzyme that converts homogentisic acid (HGA) to maleylacetoacetic acid in the tyrosine degradation pathway. The three major features of alkaptonuria are the presence of HGA in the urine, ochronosis (bluish-black pigmentation in connective tissue), and arthritis of the spine and larger joints. Oxidation of the HGA excreted in the urine produces a melanin-like product and causes the urine to turn dark upon standing. Ochronosis occurs only after age 30 years; arthritis often begins in the third decade. Other manifestations include pigment deposition, aortic or mitral valve calcification or regurgitation and occasionally aortic dilatation, renal stones, and prostate stones.